2007•Medical Journal of West ChinaRequires access

Efficacy of aripiprazole and risperidone in the treatment of schizophrenia

Zhang Yi-jie

Abstract

Objective To analyse the efficacy and side effect of aripiprazole in patients with schizophrenia.Methods 60 patients with schizophrenia were divided into aripiprazole group or risperidne group for treatment of 6 weeks.The efficacy and side effect were evaluated with PANSS,CGI and TESS,respectively.Results There were no significant difference in the efficacy between aripiprazole group and risperidne group.The side effects of aripiprazole were milder and fewer than those of risperidone.Conclusion Aripiprazole has an obvious efficacy in ameliorating the symptoms of patients with schizophrenia.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Aripiprazole, Risperidone, Medicine, Schizophrenia (object-oriented programming), Side effect (computer science), Clinical efficacy, Significant difference, Psychiatry